Home Ingredients Hesperidin
Cardiovascular

Hesperidin

Evidence Level
Strong
2 Clinical Trials
5 Documented Benefits
4/5 Evidence Score

Hesperidin is a flavanone glycoside found primarily in citrus fruits — particularly oranges, grapefruits, and lemons (highest concentration in peel and pith). Studied for vascular health, chronic venous insufficiency, hemorrhoids, and capillary fragility. Used widely in Europe (combined with diosmin as Daflon®/Detralex®) for venous diseases. Strong evidence for venous and microcirculation support.

Studied Dose 500-1,000 mg/day general; 450-900 mg/day combined with diosmin for venous insufficiency (Daflon® 500 mg = 450 mg diosmin + 50 mg hesperidin)
Active Compound Hesperidin (4'-methoxy-7-O-rutinosyl-naringenin)

Benefits

Chronic Venous Insufficiency Treatment

Hesperidin combined with diosmin (Daflon®/Detralex®) is established prescription medication in Europe for chronic venous insufficiency (varicose veins, leg edema, leg pain). Multiple meta-analyses and the RELIEF Study confirm efficacy. Substantial evidence base.

Supported by Trial 1

Hemorrhoid Treatment

Hesperidin/diosmin is first-line nonsurgical treatment for hemorrhoidal disease in many European guidelines. Reduces bleeding, pain, swelling. Comparable efficacy to many topical/surgical interventions for grade I-II hemorrhoids.

Supported by Trial 2

Microcirculation / Capillary Fragility

Reduces capillary fragility and improves microcirculation — relevant for diabetes, retinopathy, easy bruising, lymphedema. Long-established 'venotonic' agent.

Supported by Trial 2

Anti-Inflammatory / Antioxidant

Reduces inflammatory markers, oxidative stress, endothelial dysfunction — broad cardiovascular protective effects beyond just venous applications.

Supported by Trial 1, Trial 2

Modest Cardiovascular Risk Marker Effects

Some trials show modest improvements in blood pressure, lipids, endothelial function. Effect smaller than dedicated cardiovascular medications. General CV support component.

Mechanism of action

1

Venotonic / Vasoconstrictor Activity

Hesperidin (and diosmin) increase venous tone and reduce venous distensibility — basis for venous insufficiency treatment. Improves valve function and reduces venous reflux.

2

Lymphatic Drainage Enhancement

Increases lymphatic contractility — improves lymph drainage. Relevant for edema, lymphedema, lymphatic stagnation.

3

Anti-Inflammatory / Adhesion Molecule Reduction

Reduces leukocyte adhesion to endothelium, decreases inflammatory cytokines. Limits the inflammatory cascade that contributes to chronic venous disease.

4

Capillary Permeability Reduction

Decreases capillary permeability — reduces fluid leakage, improves capillary integrity. Foundational mechanism for 'capillary fragility' applications.

Clinical trials

1
Hesperidin/Diosmin for CVI — RELIEF Study (Jantet 2002)
PubMed

Large prospective international study of micronized purified flavonoid fraction (90% diosmin + 10% hesperidin) in 5,052 patients with chronic venous insufficiency for 6 months.

5,052 CVI patients (international).

Significant improvement in CVI symptoms (edema, pain, leg heaviness, cramps), quality of life. Foundational evidence supporting MPFF as venous insufficiency treatment. Multiple subsequent meta-analyses confirmed efficacy.

2
Hesperidin/Diosmin for Hemorrhoids — Meta-Analysis
PubMed

Meta-analyses and systematic reviews of MPFF (diosmin/hesperidin) for hemorrhoidal disease.

Pooled across hemorrhoid RCTs.

MPFF significantly reduces hemorrhoid bleeding, pain, swelling. Recommended in European guidelines. Reasonable first-line nonsurgical option.

Side effects and drug interactions

Common Potential side effects

Generally very well-tolerated.
Mild GI distress (nausea, abdominal pain, diarrhea).
Headache.
Skin reactions / contact dermatitis rare.
Allergic reactions to citrus rare.
Hot flushes (rare).

Important Drug interactions

Generally minimal drug interactions.
Anticoagulants — minimal effect; theoretical at very high doses.
Calcium channel blockers — theoretical interaction (citrus flavonoids modify CYP3A4); clinically minor.
Pregnancy/lactation — limited safety data for supplementation; AVOID; dietary citrus safe.

More Cardiovascular Ingredients

Cardiovascular
Niacin
Niacin, or vitamin B3, is a vital nutrient that supports energy production by serving as a…
Cardiovascular
Omega-3 Fatty Acids
Omega-3 fatty acids, primarily eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), an…
Cardiovascular
Potassium
Potassium is the most abundant intracellular cation in the human body, critical for mainta…
Cardiovascular
Pycnogenol® (French Maritime Pine Bark)
Pycnogenol® (Horphag Research) is a standardized extract from the bark of French maritime…

Explore Other Ingredients

Cognitive
Rhodiola Rosea
Rhodiola rosea is an adaptogenic herb from arctic and mountainous regions of Europe and As…
Energy
SalidroPure™ (Pure Salidroside)
SalidroPure™ is NNB Nutrition's precision-fermented pure salidroside — the primary bioacti…
Cognitive
Holy Basil (Tulsi)
Holy basil (Tulsi) is a sacred plant in Ayurvedic medicine and one of the most revered ada…

Frequently asked questions about Hesperidin

What is Hesperidin?

Hesperidin is a flavanone glycoside found primarily in citrus fruits — particularly oranges, grapefruits, and lemons (highest concentration in peel and pith).

What does Hesperidin do?

Hesperidin (and diosmin) increase venous tone and reduce venous distensibility — basis for venous insufficiency treatment. Improves valve function and reduces venous reflux. In clinical research, Hesperidin has been studied for chronic venous insufficiency treatment, hemorrhoid treatment, microcirculation / capillary fragility.

Who should take Hesperidin?

Hesperidin may be most relevant for people interested in cardiovascular. It has been clinically studied for chronic venous insufficiency treatment, hemorrhoid treatment, microcirculation / capillary fragility. As with any supplement, consult your healthcare provider before starting, especially if you have medical conditions or take prescription medications.

How long does Hesperidin take to work?

Most clinical trial effects appear over weeks of consistent use; individual response varies. Acute or same-day effects (where applicable) typically appear within hours, but most cumulative benefits — particularly those affecting biomarkers, mood, sleep quality, or chronic symptoms — require 4-12 weeks of regular use to fully assess. If you don't notice benefit after 12 weeks at the appropriate dose, it may not be your responder.

When is the best time to take Hesperidin?

For cardiovascular or metabolic goals, Hesperidin is typically taken with meals to support absorption and reduce GI sensitivity. Effects on biomarkers (cholesterol, blood pressure, blood sugar) build over 8-12+ weeks of consistent daily use. Always check product labeling and follow personalized guidance from your healthcare provider.

Is Hesperidin worth taking?

Hesperidin has strong clinical evidence (Evidence Level 4/5 on NutraSmarts) for its primary uses, with multiple randomized controlled trials and meta-analyses supporting its benefits. Whether it's worth taking depends on your specific goals, what you've already tried, your budget, and your overall supplement strategy. The honest framing: no supplement is essential for most people, and lifestyle factors (sleep, exercise, diet, stress management) typically produce larger effects than any single supplement. Hesperidin is most worth trying if its evidence-supported uses align with your specific goals.

What is the recommended dosage of Hesperidin?

The clinically studied dose for Hesperidin is 500-1,000 mg/day general; 450-900 mg/day combined with diosmin for venous insufficiency (Daflon® 500 mg = 450 mg diosmin + 50 mg hesperidin). Always follow product labeling and consult a healthcare provider for personalized dosing recommendations.

What is Hesperidin used for?

Hesperidin is studied for chronic venous insufficiency treatment, hemorrhoid treatment, microcirculation / capillary fragility. Hesperidin combined with diosmin (Daflon®/Detralex®) is established prescription medication in Europe for chronic venous insufficiency (varicose veins, leg edema, leg pain). Multiple meta-analyses and the RELIEF Study confirm efficacy.